Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-08

Clinical Trial Update: Glizigen-Viudid-External Anogenital Warts in Children and Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 trial of Glizigen-Viudid for external anogenital warts in children and adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glizigen-Viudid

Snippet

Sponsor: Catalysis SL | Conditions: External Anogenital Warts | Phase 3 | Status: COMPLETED